EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED Extrawell Pharmaceutical Holdings Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was HKD 34.1 million compared to HKD 43.46 million a year ago. Net income was HKD 45.82 million compared to HKD 88.59 million a year ago.
Basic earnings per share from continuing operations was HKD 0.0192 compared to HKD 0.0371 a year ago. Diluted earnings per share from continuing operations was HKD 0.0162 compared to HKD 0.0288 a year ago.
